Evaluation of a Novel Female Hygiene Device for Postcoital Discomfort

Not Applicable

• Conditions: Vaginal Discharge; Bacterial Vaginoses; Dyspareunia; Female Sexual Dysfunction; Vaginitis
• Interventions: Device: Tampon-like device for absorption of sexual fluids

• Registration Number: NCT04885556
• Lead Sponsor: Atlantic Health System

Brief Summary

Previous research has shown that semen deposition in the vagina after intercourse leads to dripping, discomfort, and vaginal odor. This study is evaluating a hygiene device designed to be inserted into the vagina after intercourse to absorb semen deposited into the vaginal canal to determine if there is a reduction in dripping and odor, and to determine the amount of fluids absorbed.

Detailed Description

Despite the significant number of sexual dysfunctions in women, physicians often avoid discussing these concerns in the office setting. With recent research on the role of the pelvic floor, and recently approved medical therapies for hypoactive sexual desire disorder, physicians have begun to adapt to questioning patients about libido and pain-related sexual dysfunctions. However, pain-related sexual questionnaires often focus on insertional and penetrational dyspareunia, without asking about discomfort minutes, hours, or even the day following sexual intercourse. One common compliant in ambulatory sexual medicine clinics is the bothersome dripping, odor, and discomfort women experience after sexual activity when no condom is used, and when intravaginal ejaculation occurs.

Previous studies have shown the effects of semen on alterations in the vaginal flora. These changes contribute to a multitude of clinical complaints and diagnoses, including malodor, continuous discharge after intercourse, and bacterial vaginosis (BV). The exposure of semen changes the vaginal flora by increasing the pH levels, in turn altering the bacterial growth pattern. This implies the persistent presence of semen in the vagina may be one of the causes of malodor and development of BV. Chvapil utilized gas chromatography and demonstrated that the longer period of time semen was present in the vagina, the more likely it resulted in a strong and unattractive vaginal odor. Gallo showed that an incidental diagnosis of BV was correlated with detection of sperm on gram stain, and frequent coitus with or without condom use.

The investigator's goal in this study is to evaluate a novel postcoital consumer health product and its effects on the complaints of continuous seepage of semen and vaginal odor after intercourse.

Study Timeline

• Study Start: 2021-04-05
• Study First Submitted: 2021-04-28
• Status Verified: 2021-05
• Study First Submitted QC: 2021-05-08
• Last Update Submitted: 2021-05-08
• Study First Posted: 2021-05-13
• Last Update Posted: 2021-05-13
• Primary Completion: 2021-09-15
• Study Completion: 2021-09-15

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: Female
• Target Recruitment: 30

Inclusion Criteria

• Heterosexual
• Age 25-50
• Has used tampons in the past 5 years
• Sexually active (vaginal intercourse, minimum once per week)
• Answered "moderate" to "severe" to being bothered by dripping/discomfort on Patient Global Impression of Severity (PGI-S) questionnaire "on minutes, hours, or following day"
• Willing and able to use product
• Understands, reads, writes, and speaks English

Exclusion Criteria

• Pregnant
• Currently using condoms
• Unable to use device due to poor motor function
• Chronic disease which makes prone to infection (diabetes, autoimmune)
• Recurrent yeast infections
• Recurrent Urinary tract infection (UTI) (>2 within the past year)
• Diagnosis of pelvic organ prolapse (Stage II or greater)
• Previous pelvic or vaginal surgery which, in the opinion of the investigator, may prevent proper use of product
• Unable to sign informed consent

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
1 hour use	Tampon-like device for absorption of sexual fluids	Subjects in this arm will be instructed to use the product for one hour and then remove
Immediate Use	Tampon-like device for absorption of sexual fluids	Subjects in this arm will be instructed to use the study device for 2 minutes and remove

Primary Outcome Measures

Name	Time	Method
Patient Global Impression of Improvement (PGI-I)	within 1 hour of use of product	Validated Questionnaire
Weight of Investigational Device	within 1 hour of use of product	Product weight (amount of fluid absorbed)

Trial Locations

Locations (1)

The Center for Specialized Women's Health, division of Garden State Urology; 🇺🇸 Denville, New Jersey, United States